梗阻性黄疸患者经皮经肝胆管引流术后应用异甘草酸镁治疗肝损害的疗效观察

王晓鹏; 苏河; 田宏伟; 张苏钰; 吴自燕; 安亚莉; 马云涛

doi:10.3969/j.issn.1001-5256.2014.06.022

梗阻性黄疸患者经皮经肝胆管引流术后应用异甘草酸镁治疗肝损害的疗效观察

DOI: 10.3969/j.issn.1001-5256.2014.06.022

甘肃省人民医院干四普外科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2960
- HTML全文浏览量: 16
- PDF下载量: 591
- 被引次数: 0
出版历程
- 收稿日期: 2013-11-11
- 出版日期: 2014-06-20

Clinical efficacy of magnesium isoglycyrrhizinate in treatment of liver injury among patients with obstructive jaundice after percutaneous transhepatic cholangiodrainage

Department of General Surgery, Gansu Provincial People's Hospital

摘要

摘要:
目的评价梗阻性黄疸患者经皮经肝胆管引流术（PTCD）后使用异甘草酸镁治疗肝功能损伤的临床疗效及安全性。方法选择2009年6月-2011年4月收治的梗阻性黄疸的患者共62例,在PTCD术后配合应用维生素B6、维生素C、复合辅酶静脉点滴的基础上,随机分为治疗组32例,加用异甘草酸镁100 mg;对照组30例,加用还原型谷胱甘肽1200 mg。治疗1周后,比较ALT、AST、Alb、GGT、ALP、TBil、DBil及肿瘤坏死因子（TNF）α、NF-κB的变化情况;观察与药物相关的不良反应。结果治疗1周后,治疗组与对照组TBil、DBil、ALT、AST、ALP、TNFα、NF-κB较治疗前均明显下降（P<0.05）;与对照组相比,治疗组TBil、DBil、ALT、AST、ALP、TNFα、NF-κB下降明显（P<0.05）;但对alb、ggt的改善两组治疗前后比较及组间比较差异无统计学意义（p>0.05）。结论梗阻性黄疸患者PTCD术后经异甘草酸镁治疗肝功能损伤对尽快恢复肝功能,消退黄疸,有促进作用,有更好的疗效和安全性。
- 黄疸,阻塞性 /
- 经皮经肝胆管引流术 /
- 异甘草酸镁
Abstract:
Objective To evaluate the clinical efficacy and safety of magnesium isoglycyrrhizinate in the treatment of liver injury among patients with obstructive jaundice after percutaneous transhepatic cholangiodrainage ( PTCD) . Methods Sixty- two obstructive jaundice patients with liver injury after PTCD were randomly divided into treatment group ( n = 32) and control group ( n = 30) . All patients were given vitamin B6, vitamin C, and coenzyme complex by intravenous drip. At the same time, the treatment group was given magnesium isoglycyrrhizinate ( 100 mg) after PTCD for 7 days, while the control group was given reduced glutathione ( 1200 mg) for 7 days. After treatment, the improvements in serum alanine transaminase ( ALT) , aspartate aminotransferase ( AST) , albumin ( Alb) , γ- glutamyl transpeptidase ( GGT) , alkaline phosphatase ( ALP) , total bilirubin ( TBil) , direct bilirubin ( DBil) , tumor necrosis factor- α ( TNFα) , and nuclear factor- kappa B ( NF- κB) were evaluated. The adverse reactions associated with magnesium isoglycyrrhizinate were observed. Results After treatment, both groups showed significant decreases in serum TBil, DBil, ALT, AST, ALP, TNFα, and NF- κB ( P < 0. 05) , and the treatment group had significantly higher decreases in these indices ( P < 0. 05) . However, there were no significant improvements in Alb and GGT in either group after treatment, and the two indices showed no significant differences between the two groups ( P > 0. 05) . Conclusion Treated with magnesium isoglycyrrhizinate, obstructive jaundice patients with liver injury after PTCD can regain the liver function and recover from jaundice rapidly, and magnesium isoglycyrrhizinate has good efficacy and safety.
- jaundice, obstructive /
- percutaneous transhepatic choledochus drainage /
- magnesium isoglycyrrhizinate

HTML全文

参考文献(16)

[1]DONG LP, YU F, LIU J, et al.Protective effect of magnesium isoglycyrrhizina on acute hepatic injury in mice[J].China Pharm, 2006, 17 (12) :902-904. (in Chinese) 董丽萍, 于锋, 柳镜, 等.异甘草酸镁对D-氨基半乳糖急性肝损伤模型小鼠的保护作用研究[J].中国药房, 2006, 17 (12) :902-904.

[2]WEI W, AI H, RUAN LT, et al.Ultrasound-guided percutaneous transhepatic cholangiographic draingage in treatment of obstructive jaundice[J].Chin J Interv Imaging Ther, 2012, 9 (11) :782-785. (in Chinese) 魏炜, 艾红, 阮骊韬, 等.超声引导下经皮肝穿刺胆管置管引流术治疗梗阻性黄疸[J].中国介入影像与治疗学, 2012, 9 (11) :782-785.

[3]WANG TR, WANG LT, QU YQ, et al.Comparative analysis of serum markers of cardiac function in a rabbit model of and human patients with obstructive jaundice[J].J Clin Hepatol, 2013, 29 (3) :227-229. (in Chinese) 王天然, 王蓝天, 曲远青, 等.梗阻性黄疸兔与人血清心肌标志物的比较分析[J].临床肝胆病杂志, 2013, 29 (3) :227-229.

[4]ZHANG XW, HUANG ZQ.Clinical observation and evaluation of liver functional restoring changes afer releasing from biliary obstruction[J].Chin J Hepatobiliary Surg, 1994, 2 (2) :101. (in Chinese) 张晓卫, 黄志强.胆道阻塞解除后肝功能指标的临床观察与评价[J].肝胆外科杂志, 1994, 2 (2) :101.

[5]YIN LN, ZHANG YC, ZHOU XW, et al.Clinical study of the role of glutamine in immunological function during postoperative obstructive jaundice[J].J Clin Hepatol, 2012, 28 (7) :506-508. (in Chinese) 尹兰宁, 张有成, 周晓伟, 等.谷氨酰胺对良性梗阻性黄疸患者术后免疫功能的影响[J].临床肝胆病杂志, 2012, 28 (7) :506-508.

[6]GU X, DONG LP, LIU YC, et al.Protective effect of magnesium isoglycyrrhizinate on acute hepatic injury induced by CCl4in mice[J].China Pharmacist, 2009, 2 (1) :37-39. (in Chinese) 顾新, 董丽萍, 刘宇宸, 等.异甘草酸镁对急性四氯化碳肝损伤小鼠保护作用的研究[J].中国药师, 2009, 2 (1) :37-39.

[7] CHENG Y, ZHANG J, SHANG J, et al.Prevention of free fattyacid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitro[J].Pharmacology, 2009, 84 (3) :183-190.

[8] MAO YM, ZENG MD, CHEN Y, et al.Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases:a randomized, double-blind, multi-doses, active drug controlled, multi-center study[J].Chin J Hepatol, 2009, 17 (11) :847-851. (in Chinese) 茅益民, 曾民德, 陈勇, 等.异甘草酸镁治疗ALT升高的慢性肝病的多中心、随机、双盲、多剂量、阳性药物平行对照临床研究[J].中华肝脏病杂志, 2009, 17 (11) :847-851.

[9]SUN L, SHEN J, PANG X, et al.PhaseⅠsafety and pharmacokinetic study of magnesium isoglycyrrhizinate after single and multiple intravenous doses in chinese healthy volunteers[J].J Clin Pharmacol, 2007, 47 (6) :767-773.

[10]HE Y, ZENG F, LIU Q, et al.Protective effect of magnesium isoglycyrrhizinate on ethanol-induced testicular injuries in mice[J].J Biomed Res, 2010, 24 (2) :153-160.

[11]CHENG Y, ZHANG J, SHANG J, et al.Prevention of free fatty acid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitro[J].Pharmacology, 2009, 84 (3) :183-190.

[12]CHEN KJ, CHEN WY, CHEN X, et al.Increased elimination of paclitaxel by magnesium isoglycyrrhizinatein epithelial ovarian cancer patients treated with paclitaxel plus cisplatin:a pilot clinical study[J].Eur J Drug Metab Pharmacokinet, 2014, 39 (1) :25-31.

[13]HAN DL, YUAN JB, WANG YQ, et al.Study on the liver damage and toxicity materials variation in serum for obstructive jaundice rats[J].J Hebei North Univ:Med Edit, 2010, 27 (1) :33-35. (in Chinese) 韩德兰, 苑建斌, 王永清, 等.梗阻性黄疸大鼠肝脏损害及血清毒性物质变化[J].河北北方学院学报:医学版, 2010, 27 (1) :33-35.

[14]FRANGOGIANNIS NG.Chemokines in ischemia and reperfusion[J].Thromb Haemost, 2007, 97 (5) :738-747.

[15]MA XL, LI YH, GAO JX, et al.Expression of inducible nitric oxide synthase in the liver is under the control of nuclear factor kappa B in concanavalin A-induced hepatitis[J].J Gastroenterol Hepatol, 2008, 23 (7) :231-235.

[16]SON G, IIMURO Y, SEKI E, et al.Selective inactivation of NFkappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis[J].Am J Physiol Gastrointest Liver Physiol, 2007, 293 (3) :631-639.

施引文献

资源附件(0)

访问统计